257 related articles for article (PubMed ID: 37687263)
1. Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.
Docampo-Palacios ML; Ramirez GA; Tesfatsion TT; Okhovat A; Pittiglio M; Ray KP; Cruces W
Molecules; 2023 Sep; 28(17):. PubMed ID: 37687263
[TBL] [Abstract][Full Text] [Related]
2. Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance.
Graziano S; Varì MR; Pichini S; Busardo FP; Cassano T; Di Trana A
Curr Neuropharmacol; 2023; 21(12):2424-2430. PubMed ID: 37357519
[TBL] [Abstract][Full Text] [Related]
3. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review.
Ujváry I
Drug Test Anal; 2024 Feb; 16(2):127-161. PubMed ID: 37269160
[TBL] [Abstract][Full Text] [Related]
4. Hexahydrocannabinol on the Light Cannabis Market: The Latest "New" Entry.
Casati S; Rota P; Bergamaschi RF; Palmisano E; La Rocca P; Ravelli A; Angeli I; Minoli M; Roda G; Orioli M
Cannabis Cannabinoid Res; 2024 Apr; 9(2):622-628. PubMed ID: 36445181
[No Abstract] [Full Text] [Related]
5. Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).
Russo F; Vandelli MA; Biagini G; Schmid M; Luongo L; Perrone M; Ricciardi F; Maione S; Laganà A; Capriotti AL; Gallo A; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
Sci Rep; 2023 Jul; 13(1):11061. PubMed ID: 37422571
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
7. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
Hempel B; Xi ZX
Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
[TBL] [Abstract][Full Text] [Related]
8. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.
Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886
[No Abstract] [Full Text] [Related]
9. Cannabis and cannabinoids: pharmacology and therapeutic potential.
Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
11. In vitro activation of the CB
Persson M; Kronstrand R; Evans-Brown M; Green H
Drug Test Anal; 2024 Jun; ():. PubMed ID: 38894658
[TBL] [Abstract][Full Text] [Related]
12. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
13. Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC).
Nasrallah DJ; Garg NK
ACS Chem Biol; 2023 Sep; 18(9):2023-2029. PubMed ID: 37578929
[TBL] [Abstract][Full Text] [Related]
14. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
[TBL] [Abstract][Full Text] [Related]
15. Cannabis: discrimination of "internal bliss"?
Wiley JL
Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
[TBL] [Abstract][Full Text] [Related]
16. Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation.
Raz N; Eyal AM; Zeitouni DB; Hen-Shoval D; Davidson EM; Danieli A; Tauber M; Ben-Chaim Y
Biochem Pharmacol; 2023 Jun; 212():115548. PubMed ID: 37084981
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
[TBL] [Abstract][Full Text] [Related]
20. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
